DSM strikes distribution agreement for Reducose

20 Mar 2019

DSM and Phynova have signed a global distribution and collaboration agreement for Reducose, a patented, natural ingredient for healthy blood glucose levels.

DSM strikes distribution agreement for Reducose

DSM and Phynova have signed a global distribution and collaboration agreement for Reducose, a patented, natural ingredient for healthy blood glucose levels. Reducose is backed by several clinical studies and it has regulatory approvals in multiple regions across the world.

Phynova CEO Robert Miller said: “We are delighted to work with DSM, the leading global health and nutrition ingredient specialist. Along with the distribution and sales of Reducose we will collaborate closely with them on product development, clinical research, regulatory approvals and marketing.”

Ivo Lansbergen, VP Global Strategic Marketing, DSM Human Nutrition and Health, said: “Phynova is a strategic partner for DSM to provide the right nutritional solutions to address the ever-growing health concerns linked to maintaining healthy blood glucose. The combined strengths of DSM and Phynova provide an excellent platform for addressing this major societal challenge.”

Reducose is a water extract of white mulberry leaves (Morus alba), a plant that has been used for centuries around the world as a food and animal feed. Reducose can be added in small quantities to foods and drinks or taken as a small supplement. It is said to reduce the impact of high-glycaemic sugars, as well as other carbohydrates, on the body. It does this by reducing the absorption of sugars and other carbohydrates by up to 40%.